Related Experiment Video
Updated: Sep 17, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Relationships Among Glaucoma, Cardiovascular Diseases, and Mortality
Luciano Quaranta1, Alessia A Galbussera2, Mauro Tettamanti3
1Centro Oculistico Italiano, Brescia, Italy.
Insights
Glaucoma patients aged 50+ have a higher mortality risk and increased incidence of stroke. Managing comorbidities like diabetes and hypertension is crucial for improving health outcomes in glaucoma individuals.
Area of Science:
- Ophthalmology
- Public Health
- Epidemiology
Background:
- Glaucoma is a leading cause of irreversible blindness globally.
- Understanding comorbidity and mortality risks in glaucoma patients is essential for public health.
- Previous studies have not fully elucidated the mortality and comorbidity profiles of incident glaucoma cases.
Purpose of the Study:
- To investigate comorbidity rates and mortality risk in patients with newly diagnosed glaucoma.
- To compare cardiovascular disease incidence between glaucoma patients and controls.
- To identify factors influencing outcomes in glaucoma patients.
Main Methods:
- Retrospective analysis of administrative data from the Lombardy Region (Italy) from 2017-2020.
- Inclusion of 14,138 incident glaucoma cases and 42,414 controls aged 50 and above.
- Ascertainment of glaucoma using drug prescriptions, hospitalizations, interventions, and healthcare co-payment exemptions.
Main Results:
- Glaucoma patients (11.6%) had a higher mortality rate than controls (10.5%), with a hazard ratio of 1.07.
- Increased incidence of stroke was observed in glaucoma patients (HR 1.10).
- Glaucoma patients exhibited higher comorbidity rates, notably for diabetes mellitus (16.7% vs. 11.0%) and hypertension (62.2% vs. 58.1%).
Conclusions:
- Glaucoma is associated with an elevated risk of mortality and stroke.
- Age significantly influences mortality and peripheral arterial disease outcomes in glaucoma patients.
- Effective management of comorbidities is vital for improving the health and quality of life of individuals with glaucoma.
Introduction:
In order to better understand comorbidity rates and the associated risk of death in patients with glaucoma we retrospective analyzed two groups of subjects aged 50 years and above residing in Lombardy Region (Northern Italy) following them from January 1, 2017 to February 1, 2020 (just before the COVID-19 pandemic started in Italy). The two groups were all subjects with incident glaucoma in 2017 and a 3:1 random sample stratified by age and sex of subjects without glaucoma. Main outcome was overall survival. Other outcomes were incidence of cardiovascular diseases (heart attack, stroke, and peripheral arterial disease).
Methods:
All data were taken from Lombardy Region administrative database and therefore the presence of glaucoma was ascertained using antiglaucoma drug prescriptions, being hospitalized or undergoing an intervention for glaucoma, and having a glaucoma exemption for healthcare co-payments.
Results:
The study identified 14,138 incident cases of glaucoma and selected 42,414 subjects without glaucoma. The number of deaths was higher among glaucoma subjects (11.6%) compared to those without glaucoma (10.5%). The death hazard ratio (HR) for glaucoma subjects compared to controls was 1.07 (95% CI 1.01-1.14, p = 0.015) in the adjusted model. Similarly incidence of stroke was higher in glaucoma compared to non-glaucoma subjects (HR 1.10, 95% CI 1.01-1.20), while the incidence of heart attack and peripheral arterial disease during the follow-up period was similar in the two groups. HRs varied by age classes for death and peripheral arterial disease. Individuals with glaucoma showed higher comorbidity rates compared to those without glaucoma, particularly in diabetes mellitus (16.7% vs. 11.0%) and hypertension (62.2% vs. 58.1%).
Conclusions:
Our results show an increased risk of mortality in subjects with glaucoma compared to those without glaucoma, with age being a significant factor influencing outcomes. These findings suggest the importance of monitoring and managing comorbidities in individuals with newly incident glaucoma to potentially improve their overall health outcomes and quality of life.
More Related Videos
08:30Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies